1. Home
  2. MSEX vs RAPP Comparison

MSEX vs RAPP Comparison

Compare MSEX & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Middlesex Water Company

MSEX

Middlesex Water Company

HOLD

Current Price

$53.01

Market Cap

940.9M

Sector

Utilities

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$30.27

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSEX
RAPP
Founded
1897
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
940.9M
1.2B
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
MSEX
RAPP
Price
$53.01
$30.27
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$59.25
$47.80
AVG Volume (30 Days)
145.5K
368.1K
Earning Date
10-31-2025
11-06-2025
Dividend Yield
2.71%
N/A
EPS Growth
3.71
N/A
EPS
2.39
N/A
Revenue
$194,822,000.00
N/A
Revenue This Year
$3.92
N/A
Revenue Next Year
$8.51
N/A
P/E Ratio
$22.24
N/A
Revenue Growth
6.24
N/A
52 Week Low
$44.17
$6.43
52 Week High
$67.09
$42.27

Technical Indicators

Market Signals
Indicator
MSEX
RAPP
Relative Strength Index (RSI) 53.75 62.22
Support Level $50.35 $27.81
Resistance Level $52.64 $31.00
Average True Range (ATR) 1.52 1.84
MACD 0.38 0.11
Stochastic Oscillator 84.10 83.09

Price Performance

Historical Comparison
MSEX
RAPP

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: